The increasing number of carbapenem-resistant Acinetobacter baumannii clinical isolates is
a major concern, which restricts therapeutic options for treatment of serious infections …

Background Antibiotic use is largely under-regulated in Egypt leading to the emergence of
resistant isolates. Carbapenems are last resort agents to treat Acinetobacter baumannii …

Background and objective Acinetobacter baumannii (A. baumannii) is a common
nosocomial pathogen, which developed multi-drug-resistance to different classes of …

Background In the last decade, incidences of carbapenem‐resistant Acinetobacter
baumannii have been increasingly reported worldwide. Consequently, A. baumannii was …

It has previously been shown that carbapenem-resistant Acinetobacter baumannii are
frequently detected in Saudi Arabia. The present study aimed to identify the epidemiology …

This study characterized the occurrence of carbapenem resistance of Acinetobacter
baumannii isolates in a tertiary care hospital in Saudi Arabia. From January 2010 until …

Carbapenem resistant Acinetobacter baumannii is a major global concern, especially in
countries of the Middle East and North Africa, where the antibiotic resistance rates are on the …

Objective: Acinetobacter baumannii infections are rarely diagnosed in many hospitals in
Nigeria due to a lack of capacity for the identification of the organism in spite of the clinical …

Acinetobacter baumannii is an important opportunistic pathogen due to its capabilities for
developing mechanisms of resistance to a wide range of antimicrobial agents including …

Acinetobacter baumannii is an increasingly common pathogen in healthcare settings
globally. It is frequently resistant to multiple antimicrobial agents and there are recent reports …